PVEN Press Ventures Inc (CE)

Press Ventures Inc. (OTCQB:PVEN) ("Press Ventures" or the "Company"), is pleased to announce the launch of a comprehensive website to effectively illustrate the Company's new direction into the biosafety market. "The global urgency for novel biosafety solutions has never been more evident with recent outbreaks of deadly viruses and bacteria that have claimed numerous lives," commented Mr. Edward Denkiewicz, Press Ventures' CEO. "I am extremely pleased with how the Company's new website has turned out and I'm confident that its excellent visuals and striking facts about biosafety will help explain the sector, our patented technology, as well as the global business opportunity to investors. I encourage all interested parties to visit the new website to better understand our story and how we plan to combat viruses and bacteria in a natural way without the use of any harmful chemicals." The new Press Ventures corporate website can be found at www.biosafetysolutionsinc.com. About Press Ventures Press Ventures owns the worldwide rights to the patented Cedar Leaf Oil Diffusion ("CLO-D") technology for the use of natural non-human harming vapors to kill bacteria, mold, and viruses in buildings. The patented CLO-D technology has been shown to be capable of killing many deadly bacterial and viral substances such as anthrax and H1N1 in buildings while they are still occupied. The CLO-D technology has been laboratory and field tested and the Company believes that use of the technology can provide a marked improvement in air quality and eliminate many of the most dangerous airborne bacteria, viruses, and pollutants. For additional information about CLO-D technology and Press Ventures, please visit www.biosafetysolutionsinc.com Notice Regarding Forward-Looking Statements This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, demand for natural biosafety solutions, exploitation of business opportunities, strategic business goals, size of the global market for virus and bacteria security, rise in diseases, growth of the services sterilization market, the Company's business and product development plans and projections, and market information. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products or technologies and operating as a development stage company, our ability to retain important members of our management team and attract other qualified personnel, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, our ability to develop and commercialize products based on our technology platform, and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov.

CONTACT: Investor Relations Contact:
         1-888-709-1550
         IR@kingstonir.net